Evidence map›Paper›PMID 41934661›Full record

ArticleChembiochem : a European journal of chemical biology2026

Tuneable Permeability of Cellulose Nanofibrils-based Membranes in Next-Generation Barrier-On-Chip Systems.

Vita Guarino, Johan Erlandsson, Elisa De Luca, Elisabetta Perrone, Alessandra Zizzari, Monica Bianco, Alberto Portone, Stefano Leporatti, Lars Wågberg, Giuseppe Gigli and 2 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vita GuarinoUniversity of Salento, Department of Experimental Medicine, c/o Campus Ecotekne, Lecce, Italy.ORCID https://orcid.org/0000-0001-6877-5169
Johan ErlandssonDivision of Fibre Technology, Department of Fibre and Polymer Technology, School of Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
Elisa De LucaTecnomed Puglia - Tecnopolo per la medicina di precisione (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.
Elisabetta PerroneInstitute of Nanotechnology of Consiglio Nazionale delle Ricerche (CNR NANOTEC), c/o Campus Ecotekne, Lecce, Italy.
Alessandra ZizzariInstitute of Nanotechnology of Consiglio Nazionale delle Ricerche (CNR NANOTEC), c/o Campus Ecotekne, Lecce, Italy.
Monica BiancoInstitute of Nanotechnology of Consiglio Nazionale delle Ricerche (CNR NANOTEC), c/o Campus Ecotekne, Lecce, Italy.
Alberto PortoneTecnomed Puglia - Tecnopolo per la medicina di precisione (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.
Stefano LeporattiTecnomed Puglia - Tecnopolo per la medicina di precisione (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.
Lars WågbergDivision of Fibre Technology, Department of Fibre and Polymer Technology, School of Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
Giuseppe GigliUniversity of Salento, Department of Experimental Medicine, c/o Campus Ecotekne, Lecce, Italy.
Lorenzo MoroniMaastricht University, department of complex tissue regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht, Netherlands.
Valentina ArimaTecnomed Puglia - Tecnopolo per la medicina di precisione (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.

Funding

"Biotecnologia, bioinformatica e sviluppo farmaceutico" per la creazione di un hub delle scienze di vita, piano operativo salute (fsc 2014-2020), traiettoria 4, azione 4.1-cod. t4-an-01-Regione Puglia, and CUP f83c22001560003Regione Puglia ("Tecnopolo per la medicina di precisione" -TecnoMed Puglia -Regione Puglia CUP: B84I1800054000Regione Puglia ("Tecnopolo per la medicina di precisione" -TecnoMed Puglia -Regione Puglia DGR n.2117 del 21/11/2018
6 · The paper itself

Abstract

Barriers in the human body play a crucial role in regulating the exchange of substances between compartments, with permeability alterations occurring under both physiological and pathological conditions. In vitro barrier models are essential tools for studying the mechanisms of molecular diffusion across these barriers. Traditional coculture systems or advanced organ-on-chip (OoC) platforms mostly utilize permeable membranes based on artificial, nonbiodegradable materials. In this study, we introduced cellulose nanofibrils (CNFs)-based membranes to develop a new class of in vitro barrier systems. CNFs, derived from natural sources, are nontoxic, biodegradable, optically transparent, and feature a 3D fibrillar structure that mimics the cellular basement membrane. We successfully modulated the permeability of CNF-based membranes, interposed in dual-chamber polydimethylsiloxane devices, to small molecules through chemical and enzymatic treatments, while preserving their ability to allow cell adhesion and growth. This technology holds potential for its integration in next-generation OoC devices, offering more realistic and complex models that closely mimic the physiological behavior of human barriers.

Indexed as

CelluloseLab-On-A-Chip DevicesMembranes, ArtificialNanofibersDimethylpolysiloxanesHumansMicrophysiological SystemsPermeabilityCelluloseDimethylpolysiloxanesMembranes, Artificialcellulosecellulose nanofibrilsendothelial cellsIn vitro modelorgan‐on‐chip

Identifiers

PMID41934661
PMCPMC13050281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.